earnings
IM
NASDAQ · IMVT
Immunovant, Inc.
Healthcare · Biotechnology
$33.65
Down-$0.08 (-0.24%)
Updated Oct 2, 2026, 5:41 PM
SID Score
4.8/10
Composite research score
Smart Money
58/100
Neutral
- Market cap
- 4.35B
- P/E ratio
- -9.28
- Dividend yield
- 0.00%
- 52-week range
- $22.79 – $45.42
- Volume
- 1.67M
- Avg. volume
- 1.69M
Price performance · IMVT
IMVT price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 1, 2026
IMVT closed at $33.65 after 20 trading sessions, down 13.98% for the selected period.
- Last close
- $33.65
- Period change
- -13.98%
- Period low
- $33.30
- Period high
- $39.57
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 1, 2026 | $33.56 | $34.60 | $33.30 | $33.65 | 1.67M |
| Sep 30, 2026 | $33.62 | $34.195 | $33.12 | $33.78 | 1.43M |
| Sep 29, 2026 | $33.43 | $33.525 | $32.45 | $33.46 | 1.31M |
| Sep 28, 2026 | $32.93 | $33.77 | $32.65 | $33.49 | 1.23M |
| Sep 25, 2026 | $34.00 | $34.215 | $33.17 | $33.30 | 2.35M |
| Sep 24, 2026 | $34.21 | $34.545 | $33.35 | $34.00 | 1.48M |
| Sep 23, 2026 | $36.35 | $37.00 | $33.60 | $34.54 | 3.65M |
| Sep 22, 2026 | $37.38 | $38.15 | $36.84 | $37.29 | 2.26M |
| Sep 21, 2026 | $37.23 | $37.49 | $36.55 | $37.18 | 1.03M |
| Sep 18, 2026 | $37.52 | $38.35 | $36.80 | $36.95 | 2.94M |
| Sep 17, 2026 | $37.09 | $37.68 | $36.54 | $37.65 | 1.33M |
| Sep 16, 2026 | $36.75 | $37.22 | $36.11 | $36.38 | 1.17M |
| Sep 15, 2026 | $37.43 | $37.495 | $36.19 | $36.65 | 1.57M |
| Sep 14, 2026 | $37.25 | $38.03 | $37.00 | $37.66 | 1.11M |
| Sep 11, 2026 | $38.62 | $38.93 | $37.19 | $37.36 | 1.03M |
| Sep 10, 2026 | $38.18 | $38.305 | $37.525 | $38.10 | 1.08M |
| Sep 9, 2026 | $39.11 | $39.73 | $38.67 | $38.75 | 1.02M |
| Sep 8, 2026 | $38.59 | $40.5602 | $38.34 | $39.57 | 1.51M |
| Sep 4, 2026 | $39.44 | $39.73 | $38.73 | $39.25 | 765.74K |
| Sep 3, 2026 | $39.48 | $39.48 | $38.64 | $39.12 | 1.24M |
Latest IMVT news
The latest Smart Investors Daily articles mentioning IMVT.
Stock researchResearch & News · SEC Filings
Company
Market Activity
Research & News
Loading stock research…